Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders

被引:59
作者
Creed, F
Ratcliffe, J
Fernandes, L
Palmer, S
Rigby, C
Tomenson, B
Guthrie, E
Read, N
Thompson, DG
机构
[1] Univ Manchester, Sch Psychiat & Behav Sci, Manchester M13 9WL, Lancs, England
[2] Univ Sheffield, Dept Psychiat, Sheffield, S Yorkshire, England
[3] York Univ, Ctr Hlth Econ, N York, ON M3J 1P3, Canada
[4] Univ Manchester, Sch Psychiat & Behav Sci, Manchester, Lancs, England
[5] No Gen Hosp, Inst Gen Practice, Sheffield, S Yorkshire, England
[6] Univ Manchester, Hope Hosp, Sect Gastronintestinal Sci, Manchester, Lancs, England
关键词
D O I
10.1192/bjp.186.6.507
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Irritable bowel syndrome often leads to impaired functioning. Aims To assess the contribution of psychiatric disorders to impaired outcome in severe irritable bowel syndrome. Method Patients with severe irritable bowel syndrome entering a psychological treatment trial (n=257) were interviewed using the Schedules for Clinical Assessment in Neuropsychiatry. Outcomes were number of days of restricted activity, role limitation (physical) score of the Short Form Health Survey and costs. Results At baseline, depressive disorder (29% of patients), panic (12%) and neurasthenia (35%) were associated with impairment; number of psychiatric disorders was associated in a close-response fashion (P=0.005). At follow-up, depressive disorder and neurasthenia were associated with role limitation score. Improved depression was associated with improved role functioning. Conclusions Depressive, panic and neurasthenic disorders contribute to poor outcomes in severe irritable bowel syndrome, and appropriate treatment should be available to these patients.
引用
收藏
页码:507 / 515
页数:9
相关论文
共 31 条
[1]   Burden of disease - Methods of calculating disability from mental disorder [J].
Andrews, G ;
Sanderson, K ;
Beard, J .
BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 :123-131
[2]  
Beecham J., 1992, MEASURING MENTAL HLT, V2nd
[3]   The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome [J].
Creed, F ;
Fernandes, L ;
Guthrie, E ;
Palmer, S ;
Ratcliffe, J ;
Read, N ;
Rigby, C ;
Thompson, D ;
Tomenson, B .
GASTROENTEROLOGY, 2003, 124 (02) :303-317
[4]   Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients [J].
Creed, F ;
Morgan, R ;
Fiddler, M ;
Guthrie, E ;
House, A .
PSYCHOSOMATICS, 2002, 43 (04) :302-309
[5]   Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome [J].
Creed, F ;
Ratcliffe, J ;
Fernandez, L ;
Tomenson, B ;
Palmer, S ;
Rigby, C ;
Guthrie, E ;
Read, N ;
Thompson, D .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) :860-868
[6]  
Creed F, 1999, AM J MED S5A, V107, p74S, DOI DOI 10.1016/S0002-9343(99)00083-2
[7]  
Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095
[8]  
Drossman DA, 2000, AM J GASTROENTEROL, V95, P974
[9]  
DROSSMAN DA, 1995, DIGEST DIS SCI, V40, P1
[10]   Health and disability costs of depressive illness in a major US corporation [J].
Druss, BG ;
Rosenheck, RA ;
Sledge, WH .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (08) :1274-1278